YAKUGAKU ZASSHI
The Pharmaceutical Society of Japan, established in 1880, is one of Japan’s oldest and most distinguished academic societies. The Society currently has around 18,000 members. It publishes three monthly scientific journals. Chemical and Pharmaceutical Bulletin (Chem. Pharm. Bull.) began publication in 1953 as Pharmaceutical Bulletin. It covers chemistry fields in the pharmaceutical and health sciences. Biological and Pharmaceutical Bulletin (Biol. Pharm. Bull.) began publication in 1978 as the Journal of Pharmacobio-Dynamics. It covers various biological topics in the pharmaceutical and health sciences. A fourth Society journal, the Journal of Health Science, was merged with Biol. Pharm. Bull. in 2012. Yakugaku Zasshi (Japanese for “Pharmaceutical Science Journal”) has the longest history, with publication beginning in 1881. Yakugaku Zasshi is published mostly in Japanese, except for some articles related to clinical pharmacy and pharmaceutical education, which are published in English.
The main aim of the Society’s journals is to advance the pharmaceutical sciences with research reports, information exchange, and high-quality discussion. The average review time for articles submitted to the journals is around one month for first decision. The complete texts of all of the Society’s journals can be freely accessed through J-STAGE. The Society’s editorial committee hopes that the content of its journals will be useful to your research, and also invites you to submit your own work to the journals.

Chairman of Committee
Sumio Ohtsuki
Faculty of Life Sciences, Kumamoto University
Read more
17,421 registered articles
(updated on January 24, 2021)
Online ISSN : 1347-5231
Print ISSN : 0031-6903
ISSN-L : 0031-6903
0.333
2019 Journal Impact Factor (JIF)
JOURNALS PEER REVIEWED FREE ACCESS ADVANCE PUBLICATION
Scopus Pubmed
Featured article
Volume 141 (2021) Issue 1 Pages 111-124
Current Issues in Photosafety Evaluation Read more
Editor’s picks

In this review, the authors first discuss the mechanisms of phototoxicity and how they can be evaluated. They then discuss the state of the art and challenges now faced in photosafety evaluation of pharmaceuticals and cosmetics. Additionally, they describe the latest developments in OECD test guidelines for assessing photosafety, including revisions to the 3T3 NRU phototoxicity test (TG 432) and the newly adopted ROS assay (TG 495).

View all featured articles
View all articles in Current issue
Most viewed articles Dec.2020
Share this page
Select past volume & issue
feedback
Top